— Know what they know.
Not Investment Advice

EXOZ NASDAQ

eXoZymes, Inc.
1W: -7.7% 1M: -15.0% 3M: -29.1% YTD: -47.5% 1Y: -58.8%
$5.77
+0.01 (+0.17%)
 
Weekly Expected Move ±7.5%
$5 $5 $6 $6 $7
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 29 · $53.6M mcap · 2M float · 0.355% daily turnover · Short 29% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-11-18
Earliest Filing
2024-11-18
Latest Filing
partner: 2

Counterparties (Filed by EXOZ)

2 relationships

Companies named in EXOZ's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Invizyne Technologies, Inc. — partner Company issuing common stock in an underwriting agreement 2024-11-18 View
Public Ventures, LLC — partner Underwriter purchasing firm shares and option shares from the Company 2024-11-18 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-18 Other Events; Exhibits View
2026-07-01 Material Agreement; Exhibits Agreement View
2026-06-26 Regulation FD; Exhibits View
2026-06-17 Material Agreement; Regulation FD; Exhibits Agreement View
2026-06-08 Material Agreement; Regulation FD; Exhibits Agreement View
2026-05-07 Other Events; Exhibits View
2026-04-10 Other Events; Exhibits View
2026-03-31 Other Events; Exhibits View
2026-02-05 Other Events; Financial Statements and Exhibits View
2025-12-12 Other Events; Financial Statements and Exhibits View
2025-11-13 Other Events; Financial Statements and Exhibits View
2025-10-03 Other Events; Financial Statements and Exhibits View
2025-07-28 Submission of Matters to a Vote of Security Holders View
2025-07-08 Other Events; Financial Statements and Exhibits View
2025-06-26 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-06-20 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-04-02 Other Events; Financial Statements and Exhibits View
2025-04-02 Other Events; Financial Statements and Exhibits View
2025-02-21 Departure/Election of Directors; Appointment of Officers View
2025-02-11 Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms